NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

NOVO.B.DK

236.65

+1.98%↑

GMAB.DK

1,754

+2.45%↑

HLUNB.DK

40.68

+1.6%↑

ZEAL.DK

301.4

+1.21%↑

AMBUB.DK

69.35

+1.84%↑

Search

Coloplast A-S (Class B)

Închisă

442 1.1

Rezumat

Modificarea prețului

24h

Curent

Minim

437.6

Maxim

442.1

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.901

56.063

EPS

6.32

Randament dividend

5.27

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.27%

2.45%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-19B

99B

Deschiderea anterioară

440.9

Închiderea anterioară

442

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 apr. 2026, 23:17 UTC

Câștiguri

Samsung Forecasts Record First-Quarter Operating Profit

6 apr. 2026, 23:00 UTC

Acțiuni populare

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr. 2026, 22:13 UTC

Principalele dinamici ale pieței

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr. 2026, 17:09 UTC

Principalele dinamici ale pieței

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr. 2026, 16:56 UTC

Evenimente importante

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr. 2026, 14:47 UTC

Principalele dinamici ale pieței

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr. 2026, 00:00 UTC

Evenimente importante

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr. 2026, 23:58 UTC

Market Talk
Evenimente importante

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr. 2026, 18:36 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 17:59 UTC

Market Talk
Evenimente importante

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr. 2026, 17:13 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 apr. 2026, 14:59 UTC

Câștiguri

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat